Point72 Asset Management, L.P.

13F Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol: IKT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Point72 Asset Management, L.P. ownership in Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

2025-02-14 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT). This represents 0% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Point72 Asset Management, L.P.	0%			0			$2.18	13G/A	12/31/2024	14 Feb 2025 16:08:35